The duration for which you can take Tucatinib (Tucaxen 150mg tablets) is generally until disease progression or unacceptable toxicity occurs. In clinical trials, the median duration of exposure to Tucatinib was approximately 7.3 months, with a range from less than 0.1 months to 35.1 months.
